Stephanie Burns, PA
Physician Assistant · Greenwood, INNPI 1578865069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 574 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 25.1% of the total. Among physician assistant clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 574 payments — averaging $15.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$771
- Novartis$732
- Amgen$578
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$494
- Regeneron Healthcare Solutions, Inc.$431
- plus $4K from 24 others
What the payments were for
- Speaking & faculty fees$400%
- Food & beverage$8,39396%
- Education$2803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 159 | $2,189 |
| Johnson & Johnson | 57 | $771 |
| Novartis | 57 | $732 |
| Amgen | 29 | $578 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 29 | $494 |
| Regeneron Healthcare Solutions, Inc. | 26 | $431 |
| Incyte Corporation | 18 | $364 |
| E.r. Squibb & Sons, L.L.C. | 14 | $363 |
| Sun Pharmaceutical Industries Inc. | 23 | $328 |
| Sanofi | 19 | $323 |
| Mayne Pharma Commercial LLC | 21 | $285 |
| UCB, Inc. | 13 | $278 |
| Lilly USA, LLC | 15 | $244 |
| Dermavant Sciences, Inc. | 31 | $234 |
| Galderma Laboratories, L.p. | 10 | $198 |
| Almirall LLC | 7 | $167 |
| LEO Pharma Inc. | 10 | $144 |
| Pfizer | 8 | $134 |
| EPI Health, LLC | 7 | $118 |
| Boehringer Ingelheim | 4 | $84 |
| VYNE Pharmaceuticals Inc. | 3 | $57 |
| Biofrontera Inc. | 2 | $38 |
| Organon | 5 | $36 |
| Access Pro Medical, LLC | 1 | $27 |
| Sandoz | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Convatec Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Medline Industries LP | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,713 in reported general payments places this provider in the 95th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 26 | $197,328 |
| Dupixent PenDupilumab | 39 | $163,339 |
| Cosentyx Unoready PenSecukinumab | 14 | $115,283 |
| Cosentyx (2 Syringes)Secukinumab | 15 | $108,744 |
| Dupixent SyringeDupilumab | 26 | $96,755 |
| Humira(Cf)Adalimumab | 13 | $88,194 |
| OtezlaApremilast | 17 | $82,679 |
| Fluorouracil | 86 | $6,479 |
| Clobetasol Propionate | 63 | $4,284 |
| Ketoconazole | 92 | $1,573 |
| Triamcinolone Acetonide | 93 | $1,429 |
| Metronidazole | 21 | $1,189 |
| Clindamycin Phosphate | 25 | $653 |
| Doxycycline Hyclate | 46 | $598 |
| ValacyclovirValacyclovir Hcl | 19 | $387 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisCosentyx (2 Syringes) | $732 | $108,74415 claims |
| AbbVieHumira(Cf) | $2,189 | $88,19413 claims |
| AmgenOtezla | $578 | $82,67917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Greenwood
- Jessica MeriwetherGreenwood$10K
- Brendan SweeneyGreenwood$8K
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.